Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History VINC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics VINC

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Vincerx Pharma, Inc. Common Stock

VINC
Current price
0.043 USD -0.0028 USD (-6.15%)
Last closed 0.046 USD
ISIN US92731L1061
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 214 605 USD
Yield for 12 month -99.68 %
1Y
3Y
5Y
10Y
15Y
VINC
21.11.2021 - 28.11.2021

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx bioconjugation platform combines different targeting, linker, and payload technologies to develop antibody-drug conjugates (ADC) and small molecule drug conjugates (SMDC); and provides CellTrapper technology for use in reduction of payload cellular permeability. The company develops VIP943, an antibody drug conjugate in Phase 1 dose-escalation study for relapsed/refractory acute myeloid leukemia, higher-risk MDS, and B-cell acute lymphoblastic leukemia; VIP236, an SMDC, which is in Phase 1 dose-escalation study for the treatment of patients with advanced or metastatic solid tumors; and VIP924, an anti-CXCR5 ADC that leverages the same effector chemistry in preclinical studies for b-cell malignancies. It has a collaboration with the National Institutes of Health for the Phase 1 dose-escalation of enitociclib, a highly selective cyclin-dependent kinase 9 inhibitor. The company was formerly known as Vincera Pharma, Inc. and changed its name to Vincerx Pharma, Inc. in January 2021. Vincerx Pharma, Inc. was founded in 2019 and is headquartered in San Mateo, California. Address: 1825 S. Grant Street, San Mateo, CA, United States, 94402

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

200.00 USD

P/E Ratio

Dividend Yield

Financials VINC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures VINC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-915 000 USD

Current Quarter

Last Quarter

EBITDA -24 867 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -197.53 %
PEG Ratio
Return On Equity TTM -3 136.43 %
Wall Street Target Price 200.00 USD
Revenue TTM
Book Value 0.40 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -5.79 USD
Diluted Eps TTM -5.79 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation VINC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.13
Price Book MRQ 0.097

Technical Indicators VINC

For 52 Weeks

0.038 USD 17.00 USD
50 Day MA 0.052 USD
Shares Short Prior Month 68 814
200 Day MA 3.42 USD
Short Ratio 0.10
Shares Short 137 204
Short Percent 2.72 %